3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Breast
1
Conditions
Breast Neoplasms
22
Triple Negative Breast Neoplasms
3
Prostatic Neoplasms
2
Neoplasm Metastasis
2
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Recurrence
1
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Myelodysplastic Syndromes
1
Motor Activity
1
Melanoma
1
Lymphoma
1
Lymphedema
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Inflammatory Breast Neoplasms
1
Hypertension
1
Hereditary Breast and Ovarian Cancer Syndrome
1
Fatigue
1
Esophageal Neoplasms
1
Disease Progression
1
Diabetes Mellitus
1
Death
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Risk Assessment
1
Palliative Care
1
Methods
1
Metformin
1
Dexamethasone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Diabetes Mellitus
×
Palliative Care
×
Breast
×
Clear all
NCT04836221
2023-06-18
CARES
Medstar Health Research Institute
Phase NA
Completed
63 enrolled